TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Cash & Current Investments (2020 - 2026)

Updated

TScan Therapeutics' Cash & Current Investments came in at $73.04 million for Q3 2026, down 60.4% from $184.45 million a year earlier and down 27.1% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, TScan Therapeutics' Cash & Current Investments was $152.41 million, down 47.5% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 34.4% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $290.11 million in FY2024 (+51.1%), $192.04 million in FY2023 (+60.0%), $120.03 million in FY2022 (-25.6%) and $161.41 million in FY2021 (+363.9%).
  • The Q3 2026 figure represents the lowest quarterly Cash & Current Investments since Q4 2020.
  • Year-over-year, Cash & Current Investments has declined for six consecutive quarters, with an average decline of 20.5% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q4 2021 (growth of 363.9%), and the weakest in Q3 2026 (a decline of 60.4%).
  • Business Quant data shows TCRX's Cash & Current Investments at $100.2 million (Q2 2026), $128.06 million (Q1 2026) and $152.41 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 16,287.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 4.89 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 17.23 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 10.77 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 9.65 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - 505.00 Mn
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 6.44 Bn
9 Gsk 193.54 Bn 176.38 Bn - 3.92 Bn
10 TScan Therapeutics 18.87 Mn -434.83 Mn - 73.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 73.04 Mn
Jun 30, 2026 100.20 Mn
Mar 31, 2026 128.06 Mn
Dec 31, 2025 152.41 Mn
Sep 30, 2025 184.45 Mn
Jun 30, 2025 218.05 Mn
Mar 31, 2025 251.69 Mn
Dec 31, 2024 290.11 Mn
Sep 30, 2024 271.12 Mn
Jun 30, 2024 297.68 Mn
Mar 31, 2024 162.78 Mn
Dec 31, 2023 192.04 Mn
Sep 30, 2023 215.42 Mn
Jun 30, 2023 208.84 Mn
Mar 31, 2023 95.61 Mn
Dec 31, 2022 120.03 Mn
Sep 30, 2022 137.31 Mn
Jun 30, 2022 125.60 Mn
Mar 31, 2022 140.84 Mn
Dec 31, 2021 161.41 Mn
API Access

TScan Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TCRX&period=max&api_key=YOUR_API_KEY